Citation Impact
Citing Papers
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
2008 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
The Triad of Sleep Apnea, Hypertension, and Chronic Kidney Disease: A Spectrum of Common Pathology
2016 Standout
Cyclosporine-Induced Sympathetic Activation and Hypertension after Heart Transplantation
1990
Up-regulation of kidney NAD(P)H oxidase and calcineurin in SHR: Reversal by lifelong antioxidant supplementation
2003
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Vascular mechanisms of cyclosporin-induced hypertension in the rat.
1994
Treatment of Pulmonary Arterial Hypertension
2004 Standout
Contractility of the transplanted, denervated human heart
1991
A Reversible Posterior Leukoencephalopathy Syndrome
1996 Standout
CIRCULATING ANGIOTENSIN II LEVELS UNDER REPEATED ADMINISTRATION OF LISINOPRIL IN NORMAL SUBJECTS
1992
Renal Endothelin in FK506-Induced Nephrotoxicity in Spontaneously Hypertensive Rats
1998 StandoutNobel
Omega-3 fatty acids in health and disease and in growth and development
1991 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Exercise Standards for Testing and Training
2013 Standout
The long-term course of cyclosporine-associated chronic nephropathy
1988
Psychedelics
2016 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Ventricular adrenomedullin is associated with myocyte hypertrophy in human transplanted heart
2003
Mu and kappa1 opioid-stimulated [35S]guanylyl-5′-o-(γ-thio)-triphosphate binding in cynomolgus monkey brain
1999
Age‐related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications
2003 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
2001 Standout
Post‐stroke treatment with imidapril reduces learning deficits with less formation of brain oedema in a stroke‐prone substrain of spontaneously hypertensive rats
1999
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2002 Standout
Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2
2004
T-Type Ca2+ Channels and Pharmacological Blockade: Potential Pathophysiological Relevance
1997
Polyphenols: food sources and bioavailability
2004 Standout
Rationale for Fixed-Dose Combinations in the Treatment of Hypertension
2002
Drug Interactions with Grapefruit Juice
1998
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Cyclosporine and the renin-angiotensin axis
1997
Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
2009 Standout
Sleep-Disordered Breathing in Nondialyzed Patients with Chronic Renal Failure
2006
A strategy to reduce cardiovascular disease by more than 80%
2003 Standout
Effect of Pravastatin on Outcomes after Cardiac Transplantation
1995 Standout
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
2015 Standout
Cyclosporine
1989 Standout
Sympathetic neural mechanisms in obstructive sleep apnea.
1995 Standout
Triple therapy immunosuppression in cadaveric renal transplantation
1990 StandoutNobel
International Union of Pharmacology. XLVII. Nomenclature and Structure-Function Relationships of Voltage-Gated Sodium Channels
2005 Standout
Reversal of Lesions of Diabetic Nephropathy after Pancreas Transplantation
1998 Standout
Central Sleep Apnea in Kidney Disease
2015
Exercise and Heart Transplantation
1991
Pharmacokinetic Optimisation of Angiotensin Converting Enzyme (ACE) Inhibitor Therapy
1992
Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease<SUBTITLE>Results From the AASK Trial</SUBTITLE>
2002 Standout
Cyclosporine-Induced Hypertension After Transplantation
1994
Sympathetic Neural Mechanisms of Cyclosporine-Induced Hypertension*
1996
Calcium Antagonists in the Elderly
1996
Mechanism of cyclosporine-induced sympathetic activation and acute hypertension in rats.
1994
Effects of an Endothelin Receptor Antagonist in Rats With Cyclosporine-Induced Hypertension
1995
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Effects of Calcium Antagonists on Renal Hemodynamics and Progression of Nondiabetic Chronic Renal Disease
1994
Insulin Resistance in Essential Hypertension
1987 Standout
Cellular Sodium Transport in Essential Hypertension
1986
Hydrops Fetalis, Cardiovascular Defects, and Embryonic Lethality in Mice Lacking the Calcitonin Receptor-Like Receptor Gene
2006 StandoutNobel
A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation
1994 Standout
Efficacy and safety of nicardipine for chronic, stable angina pectoris: A multicenter randomized trial
1986
Nicardipine Hydrochloride Injectable Phase IV Open-Label Clinical Trial: Study on the Anti-Hypertensive Effect and Safety of Nicardipine for Acute Aortic Dissection
2002
Cyclosporine nephrotoxicity
1986
Cyclosporine- and FK506-induced sympathetic activation correlates with calcineurin-mediated inhibition of T-cell signaling.
1993
Cyclosporine causes sympathetically mediated elevations in arterial pressure in rats.
1991
Complementary roles of gasotransmitters CO and H2S in sleep apnea
2017 StandoutNobel
Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings
2000 StandoutNobel
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
2004 StandoutNobel
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Na+-K+ transport and volume of rat erythrocytes under dietary K+ deficiency
1984
Triple therapy immunosuppression in cadaveric renal transplantation
1990 StandoutNobel
Functional Significance of Cell Volume Regulatory Mechanisms
1998 Standout
Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy
2003
Effects of chronic morphine administration on mu opioid receptor- stimulated [35S]GTPgammaS autoradiography in rat brain
1996
Task force 5: Complications
1993
Nifedipine
1995 Standout
Works of M Bellet being referenced
Need for plasma angiotensin measurements to investigate converting-enzyme inhibition in humans
1989
Evaluation of Slow Release Nicardipine in Essential Hypertension by Casual and Ambulatory Blood Pressure Measurements. Effects of Acute Versus Chronic Administration
1987
Converting‐enzyme inhibition buffers the counter‐regulatory response to acute administration of nicardipine.
1987
CENTRAL CARDIOVASCULAR EFFECTS OF NARCOTIC ANALGESICS AND ENKEPHALINS IN RATS
1980
Unmasking of the hypotensive effect of nifedipine in normotensives by addition of the angiotensin converting enzyme inhibitor benazepril
1992
Inheritance of abnormal erythrocyte cation transport in essential hypertension.
1981
Effect of nicardipine in elderly hypertensive patients.
1985
Natriuretic and renal hemodynamic effects of nicardipine in essential hypertension.
1988
Ventilatory and Occlusion Pressure Responses to Hypercapnia in Patients with Chronic Renal Failure
1984
Calcium Antagonists-ACE Inhibitors Combination Therapy
1993
Acute and Chronic Effects of a New Calcium Inhibitor, Nicardipine-on Renal Hemodynamics in Hypertension
1986
Systemic hypertension after cardiac transplantation: Effect of cyclosporine on the renin-angiotensin-aldosterone system
1985